Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1997;75(10):1534–1542. doi: 10.1038/bjc.1997.262

The association between population-based treatment guidelines and adjuvant therapy for node-negative breast cancer. British Columbia/Ontario Working Group.

C Sawka 1, I Olivotto 1, A Coldman 1, V Goel 1, E Holowaty 1, T G Hislop 1
PMCID: PMC2223498  PMID: 9166950

Abstract

This study evaluated the impact of province-wide treatment guidelines on consistency of adjuvant therapy for node-negative breast cancer. A retrospective population-based cohort study was conducted in the Canadian provinces of British Columbia, which has province-wide guidelines, and Ontario, which does not. All eligible 1991 incident cases of node-negative breast cancer in British Columbia (n = 942) and a similar number of randomly selected 1991 incident cases in Ontario (n = 938) were reviewed. Consistency of adjuvant therapy received was evaluated by stratifying cases into discrete diagnostic groups using several grouping systems, and by then comparing the distribution of treatments received within each diagnostic group in the two provinces. Recursive partitioning was also performed. We observed that patterns of pathology reporting were consistent with awareness of the factors used in the British Columbia guidelines to define indications for adjuvant therapy. Consistency of care was greater in British Columbia than in Ontario by all diagnostic grouping systems and by recursive partitioning (P < 0.001), and the observed patterns in British Columbia corresponded to the British Columbia guidelines. We conclude that population-based treatment guidelines can play a role in promoting consistent patterns of adjuvant therapy for women with node-negative breast cancer.

Full text

PDF
1542

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Audet A. M., Greenfield S., Field M. Medical practice guidelines: current activities and future directions. Ann Intern Med. 1990 Nov 1;113(9):709–714. doi: 10.7326/0003-4819-113-9-709. [DOI] [PubMed] [Google Scholar]
  2. Browman G. P., Levine M. N., Mohide E. A., Hayward R. S., Pritchard K. I., Gafni A., Laupacis A. The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation. J Clin Oncol. 1995 Feb;13(2):502–512. doi: 10.1200/JCO.1995.13.2.502. [DOI] [PubMed] [Google Scholar]
  3. Fisher B., Costantino J., Redmond C., Poisson R., Bowman D., Couture J., Dimitrov N. V., Wolmark N., Wickerham D. L., Fisher E. R. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med. 1989 Feb 23;320(8):479–484. doi: 10.1056/NEJM198902233200802. [DOI] [PubMed] [Google Scholar]
  4. Fisher B., Redmond C., Dimitrov N. V., Bowman D., Legault-Poisson S., Wickerham D. L., Wolmark N., Fisher E. R., Margolese R., Sutherland C. A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors. N Engl J Med. 1989 Feb 23;320(8):473–478. doi: 10.1056/NEJM198902233200801. [DOI] [PubMed] [Google Scholar]
  5. Fisher B., Redmond C., Fisher E. R., Caplan R. Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06. J Clin Oncol. 1988 Jul;6(7):1076–1087. doi: 10.1200/JCO.1988.6.7.1076. [DOI] [PubMed] [Google Scholar]
  6. Ford L. G., Hunter C. P., Diehr P., Frelick R. W., Yates J. Effects of patient management guidelines on physician practice patterns: the Community Hospital Oncology Program experience. J Clin Oncol. 1987 Mar;5(3):504–511. doi: 10.1200/JCO.1987.5.3.504. [DOI] [PubMed] [Google Scholar]
  7. Glick J. H., Gelber R. D., Goldhirsch A., Senn H. J. Adjuvant therapy of primary breast cancer: closing summary. Recent Results Cancer Res. 1993;127:289–300. doi: 10.1007/978-3-642-84745-5_38. [DOI] [PubMed] [Google Scholar]
  8. Gregorio D. I., Strelez L. A., Sporn J. R. Attitudes and practices regarding adjuvant chemotherapy in node-negative breast cancer. J Cancer Educ. 1990;5(3):187–192. doi: 10.1080/08858199009528063. [DOI] [PubMed] [Google Scholar]
  9. Grilli R., Apolone G., Marsoni S., Nicolucci A., Zola P., Liberati A. The impact of patient management guidelines on the care of breast, colorectal, and ovarian cancer patients in Italy. Med Care. 1991 Jan;29(1):50–63. doi: 10.1097/00005650-199101000-00005. [DOI] [PubMed] [Google Scholar]
  10. Grimshaw J., Freemantle N., Wallace S., Russell I., Hurwitz B., Watt I., Long A., Sheldon T. Developing and implementing clinical practice guidelines. Qual Health Care. 1995 Mar;4(1):55–64. doi: 10.1136/qshc.4.1.55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Johnson T. P., Ford L., Warnecke R. B., Nayfield S. G., Kaluzny A., Cutter G., Gillings D., Sondik E., Ozer H. Effect of a National Cancer Institute Clinical Alert on breast cancer practice patterns. J Clin Oncol. 1994 Sep;12(9):1783–1788. doi: 10.1200/JCO.1994.12.9.1783. [DOI] [PubMed] [Google Scholar]
  12. Kanouse D. E., Jacoby I. When does information change practitioners' behavior? Int J Technol Assess Health Care. 1988;4(1):27–33. doi: 10.1017/s0266462300003214. [DOI] [PubMed] [Google Scholar]
  13. Kelly J. T., Toepp M. C. Practice parameters: development, evaluation, dissemination, and implementation. QRB Qual Rev Bull. 1992 Dec;18(12):405–409. doi: 10.1016/s0097-5990(16)30565-6. [DOI] [PubMed] [Google Scholar]
  14. Mansour E. G., Gray R., Shatila A. H., Osborne C. K., Tormey D. C., Gilchrist K. W., Cooper M. R., Falkson G. Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study. N Engl J Med. 1989 Feb 23;320(8):485–490. doi: 10.1056/NEJM198902233200803. [DOI] [PubMed] [Google Scholar]
  15. McCarthy M., Bore J. Treatment of breast cancer in two teaching hospitals: a comparison with consensus guidelines. Eur J Cancer. 1991;27(5):579–582. doi: 10.1016/0277-5379(91)90222-y. [DOI] [PubMed] [Google Scholar]
  16. McGuire W. L. Adjuvant therapy of node-negative breast cancer. N Engl J Med. 1989 Feb 23;320(8):525–527. doi: 10.1056/NEJM198902233200811. [DOI] [PubMed] [Google Scholar]
  17. McGuire W. L., Clark G. M. Prognostic factors and treatment decisions in axillary-node-negative breast cancer. N Engl J Med. 1992 Jun 25;326(26):1756–1761. doi: 10.1056/NEJM199206253262607. [DOI] [PubMed] [Google Scholar]
  18. McPhee S. J., Richard R. J., Solkowitz S. N. Performance of cancer screening in a university general internal medicine practice: comparison with the 1980 American Cancer Society Guidelines. J Gen Intern Med. 1986 Sep-Oct;1(5):275–281. doi: 10.1007/BF02596202. [DOI] [PubMed] [Google Scholar]
  19. Olivotto A., Coldman A. J., Hislop T. G., Trevisan C. H., Kula J., Goel V., Sawka C. Compliance with practice guidelines for node-negative breast cancer. J Clin Oncol. 1997 Jan;15(1):216–222. doi: 10.1200/JCO.1997.15.1.216. [DOI] [PubMed] [Google Scholar]
  20. Olivotto I. A., Bajdik C. D., Plenderleith I. H., Coppin C. M., Gelmon K. A., Jackson S. M., Ragaz J., Wilson K. S., Worth A. Adjuvant systemic therapy and survival after breast cancer. N Engl J Med. 1994 Mar 24;330(12):805–810. doi: 10.1056/NEJM199403243301201. [DOI] [PubMed] [Google Scholar]
  21. Robles S. C., Marrett L. D., Clarke E. A., Risch H. A. An application of capture-recapture methods to the estimation of completeness of cancer registration. J Clin Epidemiol. 1988;41(5):495–501. doi: 10.1016/0895-4356(88)90052-2. [DOI] [PubMed] [Google Scholar]
  22. Shapiro D. W., Lasker R. D., Bindman A. B., Lee P. R. Containing costs while improving quality of care: the role of profiling and practice guidelines. Annu Rev Public Health. 1993;14:219–241. doi: 10.1146/annurev.pu.14.050193.001251. [DOI] [PubMed] [Google Scholar]
  23. Studnicki J., Schapira D. V., Bradham D. D., Clark R. A., Jarrett A. Response to the National Cancer Institute Alert. The effect of practice guidelines on two hospitals in the same medical community. Cancer. 1993 Nov 15;72(10):2986–2992. doi: 10.1002/1097-0142(19931115)72:10<2986::aid-cncr2820721021>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  24. Wilkins R. Use of postal codes and addresses in the analysis of health data. Health Rep. 1993;5(2):157–177. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES